• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Buoy Health Integrates with Boston Children’s to Improve Pediatric Capabilities

by Jasmine Pennic 08/08/2018 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Buoy Health

Buoy Health, an AI-focused health technology startup that develops digital tools to help people from the moment they get sick start their care on the right foot, today named Boston Children’s Hospital its first innovation partner. As part of the multi-pronged partnership, Boston Children’s Hospital will integrate Buoy’s advanced AI into its website to help parents around the globe identify the right course of treatment the moment their children’s symptoms hit.

Innovation Partnership Details

As Buoy’s first innovation partner, Boston Children’s hospital will aid Buoy in improving its pediatric capabilities.  Currently, parents concerned about their children’s symptoms gain advice from Buoy by visiting its home page, www.buoyhealth.com. Yet, now, by being placed on the Boston Children hospital’s website, Buoy will now be able to naturally train its advanced machine learning on a more diverse set of parents.  

It will also help parents identify and better understand the right course of action against simple symptoms like fever, cough, headache, rash, vomiting, fatigue or shortness of breath and if those symptoms warrant a visit to the doctor or the hospital and or if they could be better and more quickly treated by over the counter medication.

Rather than visiting the ER for symptoms stemming from a common cold, like a cough, stomachache, fever, runny nose, and congestion, Buoy has actively helped worried patients reduce triage levels significantly.

According to a recent analysis, of those people who came to Buoy who intended to go to the ER, 72 percent decided to do something less severe and of those people who thought they needed to visit urgent care, 60 percent decided they now had a better course of action. The company also found that every time someone uses Buoy, they save $32 dollars in the system.

To date, Buoy has captured the attention of leading providers, hospitals, payer organizations and venture capitalists. In the past month alone, the company has experienced rapid growth and currently sees over 4 million consumers a month.

“Deep pediatric expertise is concentrated in relatively few places – yet kids are cared for around the world.  Digital tools like Buoy allow Boston Children’s to share our pediatric expertise globally – making it accessible right at people’s fingertips and helping to make more informed decisions,” said Jean Mixer, Vice President of Digital Health at Boston Children’s Hospital.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence, Artificial Intelligence (AI) Software Platform, Buoy Health, Machine Learning, Pediatric Precision Medicine

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |